Simulations Plus, Inc. (SLP)
Simulations Plus: I See Promising Growth, But I'm Staying Neutral
Simulations Plus, Inc. excels with its AI-driven biosimulation platforms, aiding drug development, but faces challenges with margin erosion and cash flow pressures. Despite strong revenue growth and promising pipeline expansions, operational inefficiencies and rising costs raise concerns about near-term profitability. Management's ability to convert backlog into profitable revenue and stabilize margins is crucial for long-term shareholder value.
SLP's Q2 Earnings Top, Sales Up Y/Y Despite Industry Headwinds
Simulations Plus' fiscal Q2 2025 performance gains from its strong software solutions and services portfolio amid limited customer funding.
Simulations Plus, Inc. (SLP) Q2 2025 Earnings Call Transcript
Simulations Plus, Inc. (NASDAQ:SLP ) Q2 2025 Earnings Conference Call April 3, 2025 5:00 PM ET Company Participants Lisa Fortuna - IR, Financial Profiles Shawn O'Connor - CEO Will Frederick - CFO & COO Conference Call Participants David Larsen - BTIG Scott Schoenhaus - KeyBanc Capital Markets Matt Hewitt - Craig-Hallum Christine Rains - William Blair Jeff Garro - Stephens Constantine Davies - Citizen Operator Greetings, and welcome to the Simulations Plus Second Quarter Fiscal 2025 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Simulations Plus (SLP) Tops Q2 Earnings and Revenue Estimates
Simulations Plus (SLP) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.20 per share a year ago.
Simulations Plus Gears Up for Q2 Earnings: What's in the Offing?
SLP's fiscal Q2 2025 performance is likely to have benefited from continued momentum across its Software and Services segments amid budget constraints.
Simulations Plus' Q1 Earnings Lag Estimates, Revenues Surge Y/Y
SLP's fiscal first-quarter performance is driven by healthy revenue growth across its Software segment and contributions from the acquisition of Pro-ficiency.
Simulations Plus, Inc. (SLP) Q1 2025 Earnings Call Transcript
Simulations Plus, Inc. (NASDAQ:SLP ) Q1 2025 Earnings Conference Call January 7, 2025 5:00 PM ET Company Participants Lisa Fortuna - IR, Financial Profiles Shawn O'Connor - CEO Will Frederick - CFO & COO Conference Call Participants David Larsen - BTIG Francois Brisebois - Oppenheimer & Company Christine Rains - William Blair Scott Schoenhaus - KeyBanc Capital Markets Matt Hewitt - Craig-Hallum Jeff Garro - Stephens Operator Greetings, and welcome to the Simulations Plus First Quarter Fiscal 2025 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Simulations Plus (SLP) Lags Q1 Earnings Estimates
Simulations Plus (SLP) came out with quarterly earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.10 per share a year ago.
Simulations Plus Gears Up for Q1 Earnings: What's in Store?
SLP's fiscal first quarter performance is likely to have gained from strength in both Software and Services' segments.
Wall Street Analysts Predict a 56.99% Upside in Simulations Plus (SLP): Here's What You Should Know
The consensus price target hints at a 57% upside potential for Simulations Plus (SLP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Simulations Plus (SLP) Stock Jumps 8.9%: Will It Continue to Soar?
Simulations Plus (SLP) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
How Much Upside is Left in Simulations Plus (SLP)? Wall Street Analysts Think 77.52%
The consensus price target hints at a 77.5% upside potential for Simulations Plus (SLP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
